Antiviral Research

Papers
(The median citation count of Antiviral Research is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro1408
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade1346
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro690
Coronavirus membrane fusion mechanism offers a potential target for antiviral development610
Of chloroquine and COVID-19417
Type 1 interferons as a potential treatment against COVID-19393
Antiviral activities of type I interferons to SARS-CoV-2 infection333
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern294
Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites254
A potential role for integrins in host cell entry by SARS-CoV-2253
The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer238
Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions229
Hepatitis B virus biology and life cycle152
Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors113
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2113
Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2103
A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-1995
The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters90
Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential89
Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses86
A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase69
Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance66
Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B63
Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes59
Put a cork in it: Plugging the M2 viral ion channel to sink influenza54
Inhibition of herpes simplex virus by myricetin through targeting viral gD protein and cellular EGFR/PI3K/Akt pathway51
A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents47
An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral46
Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation44
Emetine suppresses SARS-CoV-2 replication by inhibiting interaction of viral mRNA with eIF4E44
Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–202043
Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro43
Immunoglobulin fragment F(ab’)2 against RBD potently neutralizes SARS-CoV-2 in vitro43
Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in vitro41
Mechanisms of HBV immune evasion40
Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis39
Current understanding of human herpesvirus 6 (HHV-6) chromosomal integration39
Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses39
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection39
Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice38
Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies37
Antiviral activity of the natural alkaloid anisomycin against dengue and Zika viruses37
Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection37
HBV replication inhibitors35
An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection34
Antiviral activity of Apigenin against buffalopox: Novel mechanistic insights and drug-resistance considerations33
Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development33
Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry33
Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo32
Burden of influenza B virus infection and considerations for clinical management32
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-232
Genetic conservation of SARS-CoV-2 RNA replication complex in globally circulating isolates and recently emerged variants from humans and minks suggests minimal pre-existing resistance to remdesivir32
Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system32
Current knowledge on Hepatitis Delta Virus replication31
A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-231
Alphavirus capsid protease inhibitors as potential antiviral agents for Chikungunya infection30
Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry30
Adoptive T-cell therapy for HBV-associated HCC and HBV infection30
Cinnamic acid inhibits Zika virus by inhibiting RdRp activity29
HBV evolution and genetic variability: Impact on prevention, treatment and development of antivirals28
Generation and characterization of Japanese encephalitis virus expressing GFP reporter gene for high throughput drug screening28
Betulinic acid exhibits antiviral effects against dengue virus infection28
Artemisinin inhibits the replication of flaviviruses by promoting the type I interferon production27
Inhibition of herpes simplex virus 1 by cepharanthine via promoting cellular autophagy through up-regulation of STING/TBK1/P62 pathway27
In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs’ cleavage by CRISPR/Cas13a system27
A synthetic STING agonist inhibits the replication of human parainfluenza virus 3 and rhinovirus 16 through distinct mechanisms26
Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors25
Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues25
The rocaglate CR-31-B (−) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo25
ML-SA1, a selective TRPML agonist, inhibits DENV2 and ZIKV by promoting lysosomal acidification and protease activity24
The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro24
Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group24
Effectiveness of pegylated interferon monotherapy in the treatment of chronic hepatitis D virus infection: A meta-analysis23
Allosteric inhibitors of the main protease of SARS-CoV-223
Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro22
The direct and indirect consequences of cytomegalovirus infection and potential benefits of vaccination22
Cathelicidin antimicrobial peptides suppress EV71 infection via regulating antiviral response and inhibiting viral binding22
Antiviral drugs targeting endosomal membrane proteins inhibit distant animal and human pathogenic viruses22
Diketo acids inhibit the cap-snatching endonuclease of several Bunyavirales22
Iminosugars: A host-targeted approach to combat Flaviviridae infections22
Drug screening identified gemcitabine inhibiting hepatitis E virus by inducing interferon-like response via activation of STAT1 phosphorylation22
Influenza A(H1N1)pdm09 virus exhibiting reduced susceptibility to baloxavir due to a PA E23K substitution detected from a child without baloxavir treatment22
Methyl-β-cyclodextrin inhibits EV-D68 virus entry by perturbing the accumulation of virus particles and ICAM-5 in lipid rafts22
Amide-containing α-hydroxytropolones as inhibitors of hepatitis B virus replication21
Antiviral efficacy against influenza virus and pharmacokinetic analysis of a novel MEK-inhibitor, ATR-002, in cell culture and in the mouse model21
Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques21
Clinical outcome and the role of antivirals in congenital cytomegalovirus infection21
Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening20
Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication20
Antiviral activities of four marine sulfated glycans against adenovirus and human cytomegalovirus20
Targeting host DEAD-box RNA helicase DDX3X for treating viral infections20
Synthesis and antiviral effect of novel fluoxetine analogues as enterovirus 2C inhibitors20
Drug screening identifies gemcitabine inhibiting rotavirus through alteration of pyrimidine nucleotide synthesis pathway20
Reasons to consider early treatment in chronic hepatitis B patients20
Perspectives on stopping nucleos(t)ide analogues therapy in patients with chronic hepatitis B19
Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target19
COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment – Meeting report from an isirv-WHO virtual conference19
Identification of potassium and calcium channel inhibitors as modulators of polyomavirus endosomal trafficking19
Hepatoprotective, antioxidant, anti-inflammatory, and antiviral activities of silymarin against mayaro virus infection19
S-adenosylmethionine-dependent methyltransferase inhibitor DZNep blocks transcription and translation of SARS-CoV-2 genome with a low tendency to select for drug-resistant viral variants18
A novel method to precisely quantify hepatitis B virus covalently closed circular (ccc)DNA formation and maintenance18
New methylene blue derivatives suggest novel anti-orthopoxviral strategies18
Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease18
Prevention and treatment of neonatal herpes simplex virus infection18
Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augm18
E3 ubiquitin ligase TRIM21 restricts hepatitis B virus replication by targeting HBx for proteasomal degradation17
5-Iodotubercidin inhibits SARS-CoV-2 RNA synthesis17
Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase17
Influenza antivirals and their role in pandemic preparedness17
MDA5 against enteric viruses through induction of interferon-like response partially via the JAK-STAT cascade17
Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies17
14-Deoxy-11,12-didehydroandrographolide inhibits apoptosis in influenza A(H5N1) virus-infected human lung epithelial cells via the caspase-9-dependent intrinsic apoptotic pathway which contributes to 17
Punicalagin as an allosteric NSP13 helicase inhibitor potently suppresses SARS-CoV-2 replication in vitro17
Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.216
Failure to bictegravir and development of resistance mutations in an antiretroviral-experienced patient16
Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening16
Characterization of contemporary influenza B recombinant viruses harboring mutations of reduced susceptibility to baloxavir marboxil, in vitro and in mice16
A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera16
Prophylaxis of ferrets with nitazoxanide and oseltamivir combinations is more effective at reducing the impact of influenza a virus infection compared to oseltamivir monotherapy16
Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir15
Sofosbuvir shows a protective effect against vertical transmission of Zika virus and the associated congenital syndrome in rhesus monkeys15
Cetylpyridinium chloride blocks herpes simplex virus replication in gingival fibroblasts15
Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro15
Next-generation sequencing for cytomegalovirus antiviral resistance genotyping in a clinical virology laboratory15
A small molecule inhibitor of MyD88 exhibits broad spectrum antiviral activity by up regulation of type I interferon15
The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection15
Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein15
Glibenclamide inhibits BK polyomavirus infection in kidney cells through CFTR blockade15
The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium14
Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysis14
Isocotoin suppresses hepatitis E virus replication through inhibition of heat shock protein 9014
A mouse model of lethal respiratory dysfunction for SARS-CoV-2 infection14
Detection of baloxavir resistant influenza A viruses using next generation sequencing and pyrosequencing methods14
Substitution-inert polynuclear platinum compounds inhibit human cytomegalovirus attachment and entry14
Vaccine strain of O/ME-SA/Ind-2001e of foot-and-mouth disease virus provides high immunogenicity and broad antigenic coverage14
Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses14
A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge14
Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs14
Phenothiazines inhibit SARS-CoV-2 cell entry via a blockade of spike protein binding to neuropilin-114
NK-lysin peptides ameliorate viral encephalopathy and retinopathy disease signs and provide partial protection against nodavirus infection in European sea bass14
Generation of a reporter yellow fever virus for high throughput antiviral assays14
Suppression effect of plant-derived berberine on cyprinid herpesvirus 2 proliferation and its pharmacokinetics in Crucian carp (Carassius auratus gibelio)14
Topoisomerase III-β is required for efficient replication of positive-sense RNA viruses14
Duration of fever and symptoms in children after treatment with baloxavir marboxil and oseltamivir during the 2018–2019 season and detection of variant influenza a viruses with polymerase acidic subun13
ACE2-Fc fusion protein overcomes viral escape by potently neutralizing SARS-CoV-2 variants of concern13
Animal models for the study of human hepatitis B and D virus infection: New insights and progress13
Pyronaridine tetraphosphate efficacy against Ebola virus infection in guinea pig13
Target verification of artesunate-related antiviral drugs: Assessing the role of mitochondrial and regulatory proteins by click chemistry and fluorescence labeling13
Enzymatically synthesized 2′-fluoro-modified Dicer-substrate siRNA swarms against herpes simplex virus demonstrate enhanced antiviral efficacy and low cytotoxicity13
A dengue type 2 reporter virus assay amenable to high-throughput screening13
Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier13
Conserved coronavirus proteins as targets of broad-spectrum antivirals13
Identification of entry inhibitors with 4-aminopiperidine scaffold targeting group 1 influenza A virus13
Anti-flavivirus activity of polyoxometalate13
In vitro and in vivo evaluation of the main protease inhibitor FB2001 against SARS-CoV-213
Reverse genetic systems of SARS-CoV-2 for antiviral research12
Acyclovir, cidofovir, and amenamevir have additive antiviral effects on herpes simplex virus TYPE 112
Potential application of antiviral coumarin in aquaculture against IHNV infection by reducing viral adhesion to the epithelial cell surface12
Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients12
Targeting the NS2B-NS3 protease of tick-borne encephalitis virus with pan-flaviviral protease inhibitors12
Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study12
Immunobiology of Crimean-Congo hemorrhagic fever12
Kill or corrupt: Mechanisms of action and drug-resistance of nucleotide analogues against SARS-CoV-212
Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors12
Comparative pathology study of Venezuelan, eastern, and western equine encephalitis viruses in non-human primates12
Functional neuraminidase inhibitor resistance motifs in avian influenza A(H5Nx) viruses12
Immunodetection assays for the quantification of seasonal common cold coronaviruses OC43, NL63, or 229E infection confirm nirmatrelvir as broad coronavirus inhibitor12
DDX3 inhibitors show antiviral activity against positive-sense single-stranded RNA viruses but not against negative-sense single-stranded RNA viruses: The coxsackie B model12
Hydroxypropyl-beta-cyclodextrin (HP-BCD) inhibits SARS-CoV-2 replication and virus-induced inflammatory cytokines12
Crystal structures of full length DENV4 NS2B-NS3 reveal the dynamic interaction between NS2B and NS312
The trimeric artesunate derivative TF27 exerts strong anti-cytomegaloviral efficacy: Focus on prophylactic efficacy and oral treatment of immunocompetent mice12
LINCS dataset-based repositioning of rosiglitazone as a potential anti-human adenovirus drug11
Small molecule inhibitors possibly targeting the rearrangement of Zika virus envelope protein11
Multivalent DNA vaccine protects against genital herpes by T-cell immune induction in vaginal mucosa11
Identification of a novel inhibitor targeting influenza A virus group 2 hemagglutinins11
Evaluation of antiviral drugs against newly emerged SARS-CoV-2 Omicron subvariants11
The NF-κB inhibitor, SC75741, is a novel antiviral against emerging tick-borne bandaviruses11
Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses11
Hepatitis D virus: Improving virological knowledge to develop new treatments11
Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method11
Infectious bronchitis virus: Identification of Gallus gallus APN high-affinity ligands with antiviral effects11
A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency11
Current status of silica-based nanoparticles as therapeutics and its potential as therapies against viruses11
Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization11
SOX9 represses hepatitis B virus replication through binding to HBV EnhII/Cp and inhibiting the promoter activity11
BX795 demonstrates potent antiviral benefits against herpes simplex Virus-1 infection of human cell lines10
Ganciclovir and maribavir susceptibility phenotypes of cytomegalovirus UL97 ATP binding region mutations detected by expanded genotypic testing10
The human α-defensin-derived peptide HD5(1–9) inhibits cellular attachment and entry of human cytomegalovirus10
Preclinical characterization of AB-506, an inhibitor of HBV replication targeting the viral core protein10
A novel cell culture model reveals the viral interference during hepatitis B and C virus coinfection10
Comparative analysis of the molecular mechanism of resistance to vapendavir across a panel of picornavirus species10
GS-441524 inhibits African swine fever virus infection in vitro10
Licochalcone A inhibits enterovirus A71 replication in vitro and in vivo10
The discovery and development of filociclovir for the prevention and treatment of human cytomegalovirus-related disease10
Identification of hepatitis B virus core protein residues critical for capsid assembly, pgRNA encapsidation and resistance to capsid assembly modulators10
BIKE regulates dengue virus infection and is a cellular target for broad-spectrum antivirals10
Reversible covalent inhibitors suppress enterovirus 71 infection by targeting the 3C protease10
High dose sofosbuvir and sofosbuvir-plus-ribavirin therapy inhibit Hepatitis E Virus (HEV) replication in a rabbit model for acute HEV infection9
Development and characterization of recombinant tick-borne encephalitis virus expressing mCherry reporter protein: A new tool for high-throughput screening of antiviral compounds, and neutralizing ant9
Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model9
Metabolic regulation of the HBV-specific T cell function9
Baloxavir-oseltamivir combination therapy inhibits the emergence of resistant substitutions in influenza A virus PA gene in a mouse model9
Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates9
A novel recombinant cccDNA-based mouse model with long term maintenance of rcccDNA and antigenemia9
Strain-dependent disease and response to favipiravir treatment in mice infected with Chikungunya virus9
Adefovir dipivoxil efficiently inhibits the proliferation of pseudorabies virus in vitro and in vivo9
Flavivirus NS4B protein: Structure, function, and antiviral discovery9
Potent inhibition of diverse Omicron sublineages by SARS-CoV-2 fusion-inhibitory lipopeptides9
The epigenetic landscapes of histone modifications on HSV-1 genome in human THP-1 cells9
The involvement of annexin A1 in human placental response to maternal Zika virus infection9
In vitro and in vivo efficacy of a novel nucleoside analog H44 against Crimean–Congo hemorrhagic fever virus9
Regulation of Cas9 by viral proteins Tat and Rev for HIV-1 inactivation9
Synergistic in-vitro antiviral effects of combination treatment using anidulafungin and T-1105 against Zika virus infection9
First clinical description of letermovir resistance mutation in cytomegalovirus UL51 gene and potential impact on the terminase complex structure9
Host-targeted nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination w9
Inhibiting cytomegalovirus replication through targeting the host electron transport chain9
Viral replicon particles protect IFNAR-/- mice against lethal Crimean-Congo hemorrhagic fever virus challenge three days after vaccination9
An efficient method for simultaneously screening for HIV, syphilis, and HCV based on one dried blood spot sample9
Chromatin-mediated epigenetic regulation of HSV-1 transcription as a potential target in antiviral therapy9
Use of the Guinea pig model of genital herpes to evaluate vaccines and antivirals: Review9
Vector-borne viruses in Turkey: A systematic review and bibliography9
Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses9
Nafamostat mesylate as a broad-spectrum candidate for the treatment of flavivirus infections by targeting envelope proteins9
Helicase primase inhibitors (HPIs) are efficacious for therapy of human herpes simplex virus (HSV) disease in an infection mouse model9
SARS-CoV-2 Permissive glioblastoma cell line for high throughput antiviral screening9
Ponesimod suppresses hepatitis B virus infection by inhibiting endosome maturation9
Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production9
Ergosterol peroxide inhibits HBV infection by inhibiting the binding of the pre-S1 domain of LHBsAg to NTCP9
A fluorescence-based, gain-of-signal, live cell system to evaluate SARS-CoV-2 main protease inhibition8
5-(Perylen-3-ylethynyl)uracil as an antiviral scaffold: Potent suppression of enveloped virus reproduction by 3-methyl derivatives in vitro8
Interference of dengue replication by blocking the access of 3′ SL RNA to the viral RNA-dependent RNA polymerase8
New directions in the experimental therapy of tick-borne encephalitis8
An antibody engineering platform using amino acid networks: A case study in development of antiviral therapeutics8
Targeting SARS-CoV-2 and host cell receptor interactions8
Safety, pharmacokinetics and pharmacodynamics of SYN023 alone or in combination with a rabies vaccine: An open, parallel, single dose, phase 1 bridging study in healthy Chinese subjects8
2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors8
Relative frequency of cytomegalovirus UL56 gene mutations detected in genotypic letermovir resistance testing8
Remdesivir inhibits the polymerases of the novel filoviruses Lloviu and Bombali virus8
Anti-viral effect in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase8
Methodology-dependent performance of serum HBV RNA in predicting treatment outcomes in chronic hepatitis B patients8
A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors8
Pemetrexed inhibits Kaposi's sarcoma-associated herpesvirus replication through blocking dTMP synthesis8
TRIM56 impairs HBV infection and replication by inhibiting HBV core promoter activity8
Niclosamide inhibits hepatitis E virus through suppression of NF-kappaB signalling8
SERS based rapid and ultrasensitive detection of Japanese Encephalitis Virus8
Endogenous cathelicidin is required for protection against ZIKV-caused testis damage via inactivating virons8
7-Deaza-7-fluoro-2′-C-methyladenosine inhibits Zika virus infection and viral-induced neuroinflammation8
Apolipoprotein M, identified as a novel hepatitis C virus (HCV) particle associated protein, contributes to HCV assembly and interacts with E2 protein8
Remodeling of immunological biomarkers in patients with chronic hepatitis C treated with direct-acting antiviral therapy8
JNJ-64794964 (AL-034/TQ-A3334), a TLR7 agonist, induces sustained anti-HBV activity in AAV/HBV mice via non-cytolytic mechanisms8
0.028007030487061